Unlike MSI-H colorectal cancers in which hypermethylation of MLH1 drives multiple target gene mutations, to date there has been little evidence for mutation of specific target genes that might drive or alter the pathogenesis of colorectal cancer with loss of MSH3 function. This evidence concerns the gene MLH1 and colorectal cancer.